Losing weight can often feel like a long road, especially when progress slows down despite your best efforts. For people who have been on Wegovy and seen good results but now find their weight loss has stalled, the new Wegovy 7.2mg dose could be the next step forward.
This higher-strength option is designed for those who have already worked their way through the lower doses of Wegovy and need an extra boost to continue their journey. By building on the same proven science of Semaglutide, Wegovy 7.2mg aims to help you break through plateaus, manage your appetite more effectively, and keep moving towards your goals.
If you’re wondering what this new dose means, who it’s for, and how it works, keep reading. We will cover everything you need to know before discussing it with your healthcare provider.
Wegovy 7.2mg is the Wegovy latest strength and the newest option in the range of prescription weight-loss injections. It contains Semaglutide, a medication approved for chronic weight management in adults with obesity or overweight who also have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
Like other Wegovy doses, it is taken once weekly via a pre-filled injection pen. The difference is in the strength. Wegovy 7.2mg is designed for people who have already worked up to and tolerated lower doses but need additional support to keep losing weight or maintain their progress.
Wegovy 7.2mg works in the same way as the lower doses but delivers a higher amount of its active ingredient, Semaglutide, for stronger appetite control and potentially greater weight-loss results. This higher dose is intended for people who have already built up to and tolerated the lower strengths but need extra support to keep progressing or overcome a weight-loss plateau.
Once injected, Wegovy 7.2mg interacts with the body’s appetite regulation systems to:
These effects make it easier to eat less without feeling deprived, which is key for achieving steady, sustainable weight loss. The medication’s benefits build gradually, so consistency is important. Most people notice reduced hunger early on, but the full effects typically appear after several weeks of regular use.
Wegovy 7.2mg is designed to build on the results achieved with lower doses, offering a stronger effect for people who have reached a weight-loss plateau or need additional support to maintain progress. While research on this latest strength is still emerging, the benefits are expected to be consistent with, and in some cases greater than, the outcomes seen with the standard 2.4mg maintenance dose.
In UK clinical studies, Wegovy 2.4 mg, combined with a reduced-calorie diet and increased activity, helped patients lose up to 15% of their body weight over 68 weeks. For someone weighing 230 lb, this equals roughly 28 lb. Higher doses like 7.2 mg may help those who plateau achieve further results.
Effectiveness can vary depending on factors such as:
It’s important to remember that Wegovy 7.2mg is not a quick fix. The best results come when it is used as part of a long-term plan that includes healthy eating, regular movement, and ongoing support from a healthcare provider.
Novo Nordisk developed Wegovy 7.2mg to expand treatment options for people struggling with obesity and to support better long-term results. This higher dose gives patients and healthcare providers another option for weight management, especially when progress slows on lower doses. Many people lose a significant amount of weight early in treatment, but the body can adapt over time, leading to a plateau despite continued use and healthy lifestyle habits.
For those who have reached the standard 2.4mg maintenance dose and tolerated it well, a higher strength may help break through this plateau. With more of the active ingredient, Semaglutide, Wegovy 7.2mg can provide stronger appetite suppression, longer-lasting fullness, and reduced cravings, which can help restart weight loss.
A higher dose can be especially valuable for:
It’s important to note that Wegovy 7.2mg is not a starting point. It is for patients who have gradually progressed through lower doses to allow the body time to adapt and minimise side effects. Dose increases should only be made under medical supervision, with regular monitoring for effectiveness and tolerability.
By adding this higher strength, patients have a better chance of sustaining progress, achieving their goals, and maintaining a healthier weight in the long term.
Wegovy 2.4mg has already helped many people achieve significant weight loss, but some may take longer to reach their goals or experience a plateau. For these individuals, Wegovy 7.2mg offers a stronger appetite-suppressing effect and the potential for even greater results.
Two clinical trials, STEP UP and STEP UP T2D, studied the 7.2mg dose in people with obesity, both with and without type 2 diabetes. The findings were impressive:
When looking at other leading weight-loss medications, Wegovy 7.2mg delivers results that place it among the most effective options available today. It offers more weight loss than the standard 2.4mg dose and comes close to matching the highest doses of other top treatments.
In July 2025, Novo Nordisk submitted an application to the European Medicines Agency (EMA) to make Wegovy 7.2mg available across Europe, including the UK. Once approved for the UK market, The Care Pharmacy will also launch this higher dose through regulated channels. Until then, we continue to offer the proven Wegovy 2.4mg and Mounjaro 15mg, two of the most effective weight-loss treatments currently available.
Wegovy 7.2mg is not a starting dose. It is intended for adults who have already used and tolerated lower strengths of Wegovy, such as 2.4mg, but need an extra boost to continue losing weight or to maintain results.
You may be considered for Wegovy 7.2mg if you:
Wegovy 7.2mg is not suitable for people who have not yet titrated up through the lower doses, those with certain medical conditions (such as a history of medullary thyroid carcinoma or pancreatitis), or anyone who has had serious allergic reactions to Semaglutide.
Because this is a higher dose, any change should be made under the guidance of a healthcare professional who can monitor your progress and manage side effects.
You can also book an online consultation with The Care Pharmacy, where our healthcare team can assess your suitability for Wegovy 7.2mg and guide you through safe next steps.
Wegovy 7.2mg is not suitable for people who have not yet titrated up through the lower doses, those with certain medical conditions (such as a history of medullary thyroid carcinoma or pancreatitis), or anyone who has had serious allergic reactions to Semaglutide.
These effects are usually mild to moderate and often improve as your body adjusts to the medication. Eating smaller, balanced meals and avoiding high-fat or overly rich foods may help reduce discomfort.
Seek medical advice immediately if you develop symptoms of a severe allergic reaction, pancreatitis, or gallbladder issues.
Wegovy 7.2mg should only be prescribed and monitored by a healthcare professional, who will assess whether the benefits outweigh the risks for your individual health needs.
If you’re planning to start Wegovy 7.2mg, The Care Pharmacy can support you throughout your treatment. We provide safe access to licensed weight-loss medications in the UK, along with professional guidance to help you use them effectively.
What we offer:
With The Care Pharmacy, you can feel confident that your treatment is safe, supported, and tailored to your needs.
Wegovy 7.2mg is the highest dose of Semaglutide for weight management. It is designed for adults who have already used lower doses and need extra support to continue losing weight or overcome a plateau.
The 7.2mg dose is stronger than the earlier options, which means it may help people achieve further results when lower doses are no longer as effective. It is usually considered for patients who have tolerated treatment well but still need additional support.
For some people, yes. The higher dose can provide stronger appetite control and may support further weight loss, especially if progress has slowed on lower doses. Results will still vary depending on lifestyle and consistency with treatment.
Side effects are similar to those seen at lower doses. These may include nausea, diarrhoea, constipation, stomach pain, or headache. Most are temporary, but more serious effects are possible, so treatment should always be monitored by a healthcare professional.
Wegovy 7.2mg will be available from regulated UK pharmacies once launched. The Care Pharmacy plans to stock this dose soon. Until then, patients can access Wegovy 2.4mg or other licensed alternatives. A prescription is always required following an online or in-person consultation.
Everyone responds differently. Some people notice reduced appetite within weeks, while visible weight changes often take longer. Progress is usually steady over time and depends on consistency with treatment and healthy lifestyle habits.
Wegovy is generally prescribed on its own and not combined with other weight-loss medicines. However, it works best when used alongside healthy eating, regular activity, and ongoing lifestyle support. Always check with your healthcare provider before adding anything new.
No. Wegovy 7.2mg is intended for adults who meet specific weight and health criteria and have tolerated lower doses. It may not be suitable for people with certain medical conditions. A full medical review is needed before starting this treatment.
You’ll need to complete a consultation with a qualified healthcare professional. They will check your health, weight history, and current treatments to confirm if the 7.2mg dose is appropriate for you. The Care Pharmacy will provide this service once the higher dose becomes available.
Wegovy 7.2mg is the highest dose of Semaglutide for weight management. It is designed for adults who have already used lower doses and need extra support to continue losing weight or overcome a plateau.
The 7.2mg dose is stronger than the earlier options, which means it may help people achieve further results when lower doses are no longer as effective. It is usually considered for patients who have tolerated treatment well but still need additional support.
For some people, yes. The higher dose can provide stronger appetite control and may support further weight loss, especially if progress has slowed on lower doses. Results will still vary depending on lifestyle and consistency with treatment.
Side effects are similar to those seen at lower doses. These may include nausea, diarrhoea, constipation, stomach pain, or headache. Most are temporary, but more serious effects are possible, so treatment should always be monitored by a healthcare professional.
Wegovy 7.2mg will be available from regulated UK pharmacies once launched. The Care Pharmacy plans to stock this dose soon. Until then, patients can access Wegovy 2.4mg or other licensed alternatives. A prescription is always required following an online or in-person consultation.
Everyone responds differently. Some people notice reduced appetite within weeks, while visible weight changes often take longer. Progress is usually steady over time and depends on consistency with treatment and healthy lifestyle habits.
Wegovy is generally prescribed on its own and not combined with other weight-loss medicines. However, it works best when used alongside healthy eating, regular activity, and ongoing lifestyle support. Always check with your healthcare provider before adding anything new.
No. Wegovy 7.2mg is intended for adults who meet specific weight and health criteria and have tolerated lower doses. It may not be suitable for people with certain medical conditions. A full medical review is needed before starting this treatment.
You’ll need to complete a consultation with a qualified healthcare professional. They will check your health, weight history, and current treatments to confirm if the 7.2mg dose is appropriate for you. The Care Pharmacy will provide this service once the higher dose becomes available.
Medically reviewed by
Superintendent Pharmacist
Mounjaro can cause diarrhoea because tirzepatide slows digestion and changes gut motility, leading to more frequent bowel movements as your body adjusts. Diarrhoea is a common and usually short-term side effect, especially in the first few weeks or after a dose increase. In this guide, you’ll understand the exact reasons diarrhoea can happen on Mounjaro …
Mounjaro is now widely used for weight loss and type 2 diabetes, but with its growing popularity comes a common concern about how it fits into everyday life, especially when drinking alcohol. There’s no evidence of a reaction to drinking on Mounjaro, but it can cause some side effects like nausea and changes in blood …
Losing weight can make a real difference to your health, but with Wegovy, the benefits go even further. Research shows that Wegovy treatment not only helps reduce body weight but also supports the heart. Balancing your weight and heart health can be challenging, yet Wegovy beyond weight loss, offers a gentle way to move forward …
Wegovy, a prescription weight loss injection containing Semaglutide, has gained rapid popularity in the UK for its proven results in helping patients manage obesity. It works by mimicking a natural hormone that controls appetite and food intake. As more people turn to medical support for weight management, many are now asking about Wegovy’s long-term safety …
Wegovy has become one of the most widely prescribed weight loss treatments in the UK, helping many people achieve healthier and more confident lives. It works by mimicking a natural hormone called GLP-1, which helps you feel full for longer, reduces cravings, and slows digestion. However, even with its proven effectiveness, some people may find …
TL;DR Wegovy helps control hunger and appetite, which means you eat less and naturally consume less water through food. Include foods with high water content, such as cucumber, watermelon, and oranges to stay hydrated without feeling forced to drink water all day. Set hydration strategies like phone or smartwatch reminders to help you drink regularly …
